Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [14859]

World first as viral immunotherapy for skin cancer shows patient benefit in phase III trial

World first as viral immunotherapy for skin cancer shows patient benefit in phase III trial

ASCO 2015: Adding chemotherapy to initial therapy extends lives of men with advanced, hormone-naïve prostate cancer

ASCO 2015: Adding chemotherapy to initial therapy extends lives of men with advanced, hormone-naïve prostate cancer

ASCO 2015: Augmenting standard therapies increases cure rates for high-risk wilms tumour

ASCO 2015: Augmenting standard therapies increases cure rates for high-risk wilms tumour

ASCO 2015: Simple oral vitamin reduces risk of common, non-melanoma skin cancers

ASCO 2015: Simple oral vitamin reduces risk of common, non-melanoma skin cancers

Positive CHMP opinion recommends ibrutinib for the treatment of Waldenström’s macroglobulinemia

Positive CHMP opinion recommends ibrutinib for the treatment of Waldenström’s macroglobulinemia

Stabilised mutant p53 is an important determinant of tumour survival and a valid drug target

Stabilised mutant p53 is an important determinant of tumour survival and a valid drug target

Two-week international diet swap shows potential effects of food on colon cancer risk

Two-week international diet swap shows potential effects of food on colon cancer risk

Next generation sequencing-based tumour genomic profiling aids in detecting hereditary variants in cancer risk genes

Next generation sequencing-based tumour genomic profiling aids in detecting hereditary variants in cancer risk...

Smoking induces early signs of cancer in cheek swabs

Smoking induces early signs of cancer in cheek swabs

Novel insights in MET-proto-oncogene might lead to optimising cancer treatment

Novel insights in MET-proto-oncogene might lead to optimising cancer treatment

More from ecancer